Commentary on: Comparison of Bovine Lipid Extract Surfactant and Poractant Alfa Administered via LISA in Preterm Infants (28 + 0 to 34 + 6 Week) With Respiratory Distress Syndrome: A Randomized Controlled Trial

Documenti analoghi

• A Novel and Promising Method for Prediction of Early Surfactant Requirement in Preterm Infants With Respiratory Distress Syndrome: Pulmonary Near‐Infrared Spectroscopy
  di: Meliha Aksoy, et al.
  Pubblicazione: (2025)
• Antenatal Late Preterm Infants Exposure to Steroids (ALPINES) and Risk of Respiratory Distress and Hypoglycemia: A Retrospective Chart Review
  di: Naveed Ur Rehman Durrani, et al.
  Pubblicazione: (2025)
• Effectiveness of A Respiratory Care Protocol Including Less Invasive Surfactant Administration in ≥ 35 Weeks Gestational Age Infants
  di: Etze Chotzoglou, et al.
  Pubblicazione: (2025)
• HHHFNC Versus NIPPV Delivered by Long Narrow Cannula in Preterm Infants: Randomized Noninferiority Trial
  di: Ayala Gover, et al.
  Pubblicazione: (2025)
• Respiratory Outcomes Following Late Postnatal Dexamethasone Administration in Preterm Infants With Bronchopulmonary Dysplasia
  di: Melissa House, et al.
  Pubblicazione: (2025)